Table 1. Comparison of baseline clinical characteristics According to Metabolic Syndrome Status.
| No. of Patients (%) | |||
| Characteristic | With MetS | Without MetS | P value |
| No. of patients | 79(13.46) | 508(86.54) | |
| Gender | 0.082 | ||
| Male | 48(60.76) | 358(70.47) | |
| Female | 31(39.24) | 150(29.53) | |
| Age (yr) | 0.182 | ||
| ≧50 | 64(81.01) | 376(74.02) | |
| <50 | 15(18.99) | 132(25.98) | |
| T stage(AJCC, 7th) | 0.605 | ||
| T1a+T1b | 11(13.92) | 43(8.46) | |
| T2 | 7(8.86) | 82(16.14) | |
| T3 | 1(1.27) | 23(4.53) | |
| T4a+T4b | 60(75.95) | 360(70.87) | |
| N stage(AJCC, 7th) | 0.205 | ||
| N0 | 39(49.37) | 177(34.84) | |
| N1 | 6(7.59) | 84(16.54) | |
| T2 | 12(15.19) | 118(23.23) | |
| N3a+N3b | 22(27.85) | 129(25.39) | |
| Tumor size (cm) | 0.533 | ||
| ≤5 | 54(68.35) | 329(65.31) | |
| >5 | 25(31.65) | 179(34.69) | |
| Tumor location | 0.111 | ||
| Proximal* | 52(65.82) | 286(56.30) | |
| Distal* | 27(34.18) | 222(43.70) | |
| Degree of differentiation | 0.036 | ||
| Poorly or not differentiated, mucinous or signet ring adenocarcinoma | 53(67.09) | 390(76.77) | |
| Moderately differentiated addenocarcinoma | 18(22.78) | 102(20.08) | |
| Well differentiated addenocarcinoma | 8(10.13) | 16(3.15) | |
| Type of operation | 0.083 | ||
| Radical | 71(89.87) | 481(94.69) | |
| Palliative | 8(10.13) | 27(5.31) | |
Abbreviations and explanations: AJCC: American Joint Committee on Cancer, MetS: metabolic syndrome, Proximal*: the fundus, cardia and body of stomach, Distal*: the pylorus and antrum of stomach.